pyrilamine has been researched along with dihydroalprenolol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, RS; Snyder, SH; Tran, VT | 1 |
| Kondratenko, TY; Kuzina, NV; Severin, ES; Zacharova, IV | 1 |
2 other study(ies) available for pyrilamine and dihydroalprenolol
| Article | Year |
|---|---|
Neurotransmitter receptor localizations: brain lesion induced alterations in benzodiazepine, GABA, beta-adrenergic and histamine H1-receptor binding.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Brain; Cattle; Cerebellum; Cerebral Cortex; Corpus Striatum; Denervation; Dihydroalprenolol; gamma-Aminobutyric Acid; Guinea Pigs; Hippocampus; Medial Forebrain Bundle; Mice; Mice, Neurologic Mutants; Neurotransmitter Agents; Purkinje Cells; Pyrilamine; Rats; Receptors, Adrenergic; Receptors, Adrenergic, beta; Receptors, Drug; Receptors, Histamine; Receptors, Histamine H1; Substantia Nigra | 1980 |
The role of histamine H1-receptors in the modulation of neurotransmitter receptors activity in human lung cancer.
Topics: Acetylcholine; Adult; Dihydroalprenolol; Humans; Lung Neoplasms; Male; Middle Aged; Protein Binding; Pyrilamine; Quinuclidinyl Benzilate; Receptors, Adrenergic; Receptors, Histamine H1; Receptors, Muscarinic | 1995 |